Global saffron tablets market is projected to grow from $141.1 million in 2025 to reach $279.7 million by 2035, and is growing at a CAGR of 7.1% during the forecast period 2026-2035. The global saffron tablets market is gaining steady traction within the broader nutraceutical industry. Demand is supported by rising consumer interest in plant-based formulations for mood balance and sleep support. Standardization of saffron extract and controlled dosage formats is strengthening product credibility. Retail pharmacies and digital platforms are expanding product accessibility across urban markets. Manufacturers are focusing on clean label positioning and clinically studied ingredients to enhance trust. Regulatory oversight in several regions is also shaping formulation and labeling practices. These developments collectively reflect a gradual but sustained evolution of the market.
Browse the full report description of “Saffron Tablets Market Size, Share and Trends Analysis Report, By Type (Sugar Coated Tablet, Film Coated Tablet, and Others), By Application (Hospital Pharmacy, Retail Pharmacies, and Online Pharmacies), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/saffron-tablets-market
The growing adoption of biomarker-driven therapies is accelerating the development of targeted treatment combinations in oncology. Advances in molecular profiling are enabling more accurate identification of patient subgroups who may benefit from specific therapeutic strategies. This shift toward personalized medicine is encouraging continued clinical research and expanding the role of targeted regimens in advanced cancer management. For instance, in November 2025, HUTCHMED announced the completion of patient enrollment for the global Phase III SAFFRON trial evaluating ORPATHYS® in combination with TAGRISSO® for advanced non-small cell lung cancer with MET overexpression and or amplification following progression on TAGRISSO®. The study enrolled 338 patients across more than 230 sites in 29 countries. It aims to assess progression-free survival as the primary endpoint, along with additional efficacy and safety measures. The combination represents an oral, chemotherapy-free treatment approach under global clinical evaluation.
Global Saffron Tablets Market Competitive Landscape
The key players in the saffron tablets market are Herbalife Ltd., Glanbia plc, Nestlé Health Science S.A., Dabur India Ltd., and Blackmores Ltd., among others. These companies compete through diversified nutraceutical portfolios, established distribution networks, and strong brand positioning across retail and online channels. Market participants focus on product standardization, clean label formulations, and clinically supported ingredients to strengthen consumer confidence. Strategic expansion into emerging markets and digital commerce platforms is further shaping competitive dynamics. Continuous product development and regulatory compliance remain central to sustaining market presence.
Market Coverage
Key questions addressed by the report.
Global Saffron Tablets Market Report Segment
By Type
By Application
Global Saffron Tablets Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/saffron-tablets-market